share_log

丽珠医药(01513.HK)8月22日举行董事会会议审议及批准半年度业绩

Livzon Pharma (01513.HK) held a board of directors meeting on August 22 to review and approve the semi-annual results.

Gelonghui Finance ·  Aug 1 04:40

Livzon Pharma (01513.HK) announced that the board of directors meeting will be held on Thursday, August 22, 2024, to review and approve the unaudited semi-annual performance of the company and its subsidiaries ending on June 30, 2024, and to handle other matters.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment